Company Innoveren Scientific Inc.
Equities
IVRN
US4041243076
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0055 USD | -72.50% | -.--% | -95.26% |
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Biologics and Therapeutic Device Incubator
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -71.86% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -71.86% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 19-01-07 | |
Jeremy Daniel
DFI | Director of Finance/CFO | 48 | 19-02-03 |
Tanya Rhodes
CTO | Chief Tech/Sci/R&D Officer | 64 | 20-06-14 |
William E. Horne
BRD | Director/Board Member | 70 | 18-10-08 |
Jason Assad
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 22-01-16 | |
Chief Executive Officer | 53 | 19-01-07 | |
William E. Horne
BRD | Director/Board Member | 70 | 18-10-08 |
Chairman | 77 | 19-01-07 | |
Matthew Anderer
BRD | Director/Board Member | 59 | 22-01-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 712,710 | 253,876 ( 35.62 %) | 0 | 35.62 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-95.26% | 29.36K | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- IVRN Stock
- Company Innoveren Scientific Inc.